Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN15511689
ISRCTN15511689
Active, Not Recruiting
N/A

Multi-centre randomised controlled trial to determine the clinical and cost-effectiveness of Spotlight-AQ

Southern Health NHS Foundation Trust0 sites98 target enrollmentOctober 11, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Southern Health NHS Foundation Trust
Enrollment
98
Status
Active, Not Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35725626/ (added 21/06/2022) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37350136 (added 29/08/2023)

Registry
who.int
Start Date
October 11, 2021
End Date
September 30, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Aged \=18 years. There is no upper age limit
  • •2\. Diagnosed with type 1 diabetes or at risk of or diagnosed with type 2 diabetes (including pre\-diabetes) for at least 6 months
  • •3\. Any diabetes treatment
  • •4\. Willing/able to use the Spotlight Consultations tool
  • •5\. Ability to give informed consent
  • •6\. Ability to speak and read English fluently

Exclusion Criteria

  • •1\. Aged \<18 years
  • •2\. Mental illness that could seriously reduce their ability to participate in the study
  • •3\. Lack of capacity

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
Vaccine Response On/off Methotrexate (VROOM): does temporarily suspending methotrexate treatment for two weeks enhance COVID-19 vaccine response?
ISRCTN11442263CTU0373383
Active, Not Recruiting
N/A
Study of whole blood in frontline traumaTraumatic haemorrhageInjury, Occupational Diseases, Poisoning
ISRCTN23657907HS Blood and Transplant848
Completed
N/A
The impact of pausing BTKi therapy and responsiveness of vaccination in blood cancer patients: A randomised controlled study – the IMPROVE studyChronic lymphocytic leukaemiaCancer
ISRCTN14197181niversity of Birmingham99
Active, Not Recruiting
N/A
A clinical trial to evaluate the efficacy and safety of Shufeng Jiedu capsule in acute exacerbation of chronic obstructive pulmonary disease (COPD)Chronic obstructive pulmonary diseaseRespiratory
ISRCTN99049821Beijing University of Chinese Medicine300
Completed
N/A
Mental health intervention for children with epilepsyChildren and young people with common mental health disorders and epilepsyMental and Behavioural Disorders
ISRCTN57823197Great Ormond Street Hospital for Children NHS Foundation Trust334